ATGL Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of ATGL Antibodies for research in lipid metabolism and energy homeostasis. ATGL Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Adipose triglyceride lipase (ATGL) plays a crucial role in the hydrolysis of triglycerides into free fatty acids and glycerol, making it essential for lipid mobilization and energy production. Dysregulation of ATGL has been linked to metabolic disorders, obesity, and cardiovascular diseases, highlighting its significance in maintaining metabolic health. Understanding ATGL function contributes to knowledge about cellular energy regulation and fat storage mechanisms. Research focusing on ATGL advances our understanding of metabolic pathways and their impact on human health. Investigating ATGL activity provides insights into potential treatments for metabolic conditions. ATGL research continues to reveal new aspects of lipid metabolism and energy homeostasis. Santa Cruz Biotechnology monoclonal ATGL antibodies enable researchers worldwide to advance scientific understanding of lipid metabolism and its role in human health.